焦虑与心境障碍呈上升趋势:临床特征与风险因素分析
结果显示,任何焦虑或心境障碍的12个月患病率从10.2%升至16.7%,临床严重程度相当,但精神卫生服务使用增加、共病数量更多且起病更早;14项风险因素未显示一致性的患病率升高或相对影响增强。结论认为,患病率上升不能由风险因素变化或轻症报告增加解释,提示公众心理健康状况令人担忧地下降。
要点
- 焦虑与心境障碍12个月患病率从10.2%升至16.7%,相对增幅约半倍至两倍以上。
- 2019-2022年临床严重程度与2007-2009年相当,但精神卫生服务使用、共病数量和起病更早增加。
- 14项风险因素未显示一致性的患病率升高或相对影响增强,不能解释患病率上升。
核心结论
- 12年间焦虑与心境障碍12个月患病率持续上升,不能由风险因素变化或轻症报告增加解释,提示公众心理健康下降。
- 需采取有效预防策略、及时干预和更好的精神卫生资源分配以应对增长的临床需求。
研究设计与样本
- 覆盖2007-2009年(NEMESIS-2,n=6646)和2019-2022年(NEMESIS-3,n=4969)两个时期。
- 诊断采用复合国际诊断访谈3.0(CIDI 3.0)确定。
主要发现
- 2019-2022年所有焦虑与心境障碍的12个月患病率均显著高于2007-2009年,相对增幅约半倍至两倍以上。
- 任何焦虑或心境障碍的12个月患病率从10.2%升至16.7%。
- 2019-2022年临床特征严重程度相当,但精神卫生服务使用增加、共病障碍数量更多且起病更早。
- 14项风险因素未显示一致性的患病率升高或相对影响随时间增强的证据。
临床怎么用
- 临床应关注焦虑与心境障碍患病率上升趋势,及时识别共病数量增加和起病更早的患者。
- 需加强预防策略和早期干预,并合理分配精神卫生资源以应对增长的临床需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increase in mental disorders has been suggested, but the interpretation of such trends remains unclear. This study examines changes in the 12-month prevalence of anxiety and mood disorders over 12 years and evaluates whether clinical characteristics or sociodemographic, vulnerability and health-lifestyle risk factors contributed to these trends. AIMS: To assess trends in the 12-month prevalence of anxiety disorders (i.e. panic disorder, agoraphobia, social anxiety disorder or generalised anxiety disorder) and mood disorders (major depressive disorder, dysthymia or bipolar disorder) and explore whether changes in clinical profiles or risk factors influenced these trends. METHOD: Data from 11 615 respondents (mean age 43.5 years, 53.5% female) in the Netherlands Mental Health Survey and Incidence Studies (NEMESIS) were analysed, covering 2007-2009 (NEMESIS-2, n = 6646) and 2019-2022 (NEMESIS-3, n = 4969). Diagnoses were determined using the Composite International Diagnostic Interview 3.0. RESULTS: The 12-month prevalence of all anxiety and mood disorders was significantly higher in 2019-2022 compared to 2007-2009, with relative increases across disorders ranging from approximately a half to more than double their previous rates. Any anxiety or mood disorder increased from 10.2 to 16.7%. Clinical profiles were equally severe in 2019-2022; rather, there was increased mental health care use, a higher number of comorbid disorders and earlier onset. Examination of 14 risk factors showed no consistent evidence of greater prevalence or increased relative impact over time. CONCLUSIONS: There was a consistent rise in the 12-month prevalence of anxiety and mood disorders over 12 years. This increase was not explained by changes in risk factors or less severe disorder reporting. Instead, these findings suggest a concerning decline in public mental health, highlighting the need for effective prevention strategies, timely interventions and better mental health resource allocation to address growing clinical demands.
引用
- Gkitakou A, Have MT, Batelaan NM, et al. Anxiety and mood disorders on the rise: exploring clinical profiles and risk factors. Br J Psychiatry. 2025. PMID: 41199452. doi:10.1192/bjp.2025.10454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。